All articles tagged with #dissolution failure
The FDA has classified a recall of 13,567 bottles of chlorthalidone 25mg tablets as Class II after they failed dissolution tests. This is the second recall for this specific medication and manufacturer in three months, affecting patients nationwide who rely on the drug for hypertension and fluid retention.
More than 11,000 bottles of chlorthalidone tablets (25 mg) used to treat high blood pressure have been recalled nationwide after a manufacturing issue caused dissolution specifications to fail. Inventia Healthcare Limited initiated the voluntary recall on June 5, with 100-count bottles (Lot RISA24001) and 1,000-count bottles (Lot RISB24002) distributed in the U.S. by Rising Pharma Holdings Inc. The FDA has not yet assigned a recall classification, and no public press release had been issued; patients should contact their pharmacist or healthcare provider if they believe they have a recalled bottle and should not stop taking prescribed medication without medical advice.